[HTML][HTML] Major amputation rates in patients with peripheral arterial disease aged 50 years and over in Denmark during the period 1997–2014 and their relationship …

LS Londero, A Hoegh, K Houlind, J Lindholt - European Journal of …, 2019 - Elsevier
Objective The aim of this nationwide study was to provide insight into the incidence and
geographical distribution of vascular services and major amputations in patients with …

Two-year follow-up of vascular events in peripheral arterial disease treated with antiplatelet agents: a prospective observational multicenter cohort study (SEASON)

Y Higashi, T Miyata, H Shigematsu, H Origasa… - Scientific Reports, 2017 - nature.com
The present analysis was intended to evaluate the real-world management of peripheral
arterial disease (PAD) in Asia, and to explore cardiovascular events in patients with PAD …

[HTML][HTML] Peripheral artery disease leading to major amputation: Trends in revascularization and mortality over 18 years

L Abry, S Weiss, V Makaloski, AG Haynes… - Annals of vascular …, 2022 - Elsevier
Background Patients with peripheral artery disease (PAD) are at risk for amputation. The aim
of this study was to assess the type of revascularization prior to and the 30-day mortality rate …

[HTML][HTML] Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry

S Khan, M Flather, R Mister, N Delahunty… - European journal of …, 2007 - Elsevier
BACKGROUND: Peripheral arterial disease (PAD) is often associated with risk factors
including cigarette smoking, hypertension and hypercholesterolaemia, and patients have a …

The contemporary safety and effectiveness of lower extremity bypass surgery and peripheral endovascular interventions in the treatment of symptomatic peripheral …

TT Tsai, TF Rehring, RK Rogers, SM Shetterly… - Circulation, 2015 - Am Heart Assoc
Background—Treatment for symptomatic peripheral artery disease includes lower extremity
bypass surgery (LEB) and peripheral endovascular interventions (PVIs); however, limited …

Optimal strategy for antiplatelet therapy after endovascular revascularization for lower extremity peripheral artery disease

S Cho, YJ Lee, YG Ko, TS Kang, SH Lim… - Cardiovascular …, 2019 - jacc.org
Objectives The aim of this study was to investigate the optimal strategy for antiplatelet
therapy in patients with lower extremity peripheral artery disease (PAD) after endovascular …

[HTML][HTML] Rationale and methods of the IDOMENEO health outcomes of the peripheral arterial disease revascularisation study in the GermanVasc registry

ES Debus, L Kriston, T Schwaneberg, S Hischke… - Vasa, 2018 - econtent.hogrefe.com
Background: Atherosclerotic disease of the lower extremity arteries (PAD) remains a
significant burden on global healthcare systems with increasing prevalence. Various …

Mortality following operations for lower extremity peripheral arterial disease

TC Collins, D Nelson, JS Ahluwalia - Vascular Health and Risk …, 2010 - Taylor & Francis
Background We sought to identify risk factors associated with mortality following surgery for
peripheral arterial disease (PAD). Methods We evaluated the association between levels of …

Trends in lower extremity artery disease repair incidence, comorbidity, and mortality: a Danish nationwide cohort study, 1996–2018

A Møller, N Eldrup, J Wetterslev… - Vascular Health and …, 2024 - Taylor & Francis
Background The prevalence of occlusive lower extremity artery disease (LEAD) is rising
worldwide while European epidemiology data are scarce. We report incidence and mortality …

Smoking cessation is the least successful outcome of risk factor modification in uninsured patients with symptomatic peripheral arterial disease

KH Huen, R Chowdhury, SM Shafii, LP Brewster… - Annals of Vascular …, 2015 - Elsevier
Background Patients with peripheral arterial disease (PAD) have multiple atherosclerotic
risk factors. Risk factor modification can reduce severity of disease at presentation and …